Vanguard Group Inc Exicure, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Exicure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 40,093 shares of XCUR stock, worth $12,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,093
Previous 40,093
-0.0%
Holding current value
$12,829
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XCUR
# of Institutions
21Shares Held
860KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$90,1230.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$90,1230.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny65.6KShares$20,9920.0% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$18,0860.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny34.8KShares$11,1360.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $1.59M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...